This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
A long-acting isomer of Ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K/AKT and Smad2 pathway inhibition.
IUBMB life, 72(12), 2611-2626
Citation
Qiu, Yueyuan; Wang, Zhaowei; Zhang, Xutao; Huang, Ping; Zhang, Wangqian; Zhang, Kuo; Wang, Shuning; He, Lei; Guo, Yanhai; Xiang, An; Zhang, Cun; Hao, Qiang; Li, Meng; Li, Weina; Zhang, Yingqi. (2020). A long-acting isomer of Ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K/AKT and Smad2 pathway inhibition.. IUBMB life, 72(12), 2611-2626. https://doi.org/10.1002/iub.2389